She’s had two healthy pregnancies since undergoing the trial, which uses modified white blood cells to attack cancer cells. Doctors believe she's the longest-surviving cancer patient to have received the pioneering CAR-T therapy.

Cancer treatment, primarily chemotherapy, is associated with impaired cardiorespiratory fitness years after treatment has ended and regardless of cancer subtype, according to a meta-analysis published in JACC: CardioOncology.

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children with neuroblastoma, with one patient remaining cancer-free for over 18 years.

CAR-T-cell therapy treated a girl with a rare childhood cancer, raising hopes for future recipients of the approach.